To Use or Not to Use Metformin in Cerebral Ischemia: A Review of the Application of Metformin in Stroke Rodents

Overview

Journal Stroke Res Treat

Publisher Wiley

Date 2017 Jun 22

PMID 28634570

Citations 23

Authors

Isaac Arbelaez-Quintero

Mauricio Palacios

Affiliations

Soon will be listed here.

Abstract

Ischemic strokes are major causes of death and disability. Searching for potential therapeutic strategies to prevent and treat stroke is necessary, given the increase in overall life expectancy. Epidemiological reports indicate that metformin is an oral antidiabetic medication that can reduce the incidence of ischemic events in patients with diabetes . Its mechanism of action has not been elucidated, but metformin pleiotropic effects involve actions in addition to glycemic control. AMPK activation has been described as one of the pharmacological mechanisms that explain the action of metformin and that lead to neuroprotective effects. Most experiments done in the cerebral ischemia model, via middle cerebral artery occlusion in rodents (MCAO), had positive results favoring metformin's neuroprotective role and involve several cellular pathways like oxidative stress, endothelial nitric oxide synthase activation, activation of angiogenesis and neurogenesis, autophagia, and apoptosis. We will review the pharmacological properties of metformin and its possible mechanisms that lead to neuroprotection in cerebral ischemia.

Citing Articles

Modulation of the Oxidative Stress and ICAM-1/TLR4/NF-Κβ Levels by Metformin in Intestinal Ischemia/Reperfusion Injury in Rats.

Turan I, Ozacmak H, Ozacmak V, Barut F Cell Biochem Biophys. 2025; .

PMID: 40009289 DOI: 10.1007/s12013-025-01687-5.

Therapeutic Effects of Metformin on Central Nervous System Diseases: A Focus on Protection of Neurovascular Unit.

Cai C, Gu C, Meng C, He S, Thashi L, Deji D Pharm Res. 2024; 41(10):1907-1920.

PMID: 39375240 DOI: 10.1007/s11095-024-03777-0.

Effects of Prior Metformin Use on Stroke Outcomes in Diabetes Patients with Acute Ischemic Stroke Receiving Endovascular Treatment.

Kim C, Kim Y, Sohn J, Sung J, Han S, Lee M Biomedicines. 2024; 12(4).

PMID: 38672100 PMC: 11048027. DOI: 10.3390/biomedicines12040745.

Advancements in research on the immune-inflammatory mechanisms mediated by NLRP3 inflammasome in ischemic stroke and the regulatory role of natural plant products.

Yang K, Zeng L, He Q, Wang S, Xu H, Ge J Front Pharmacol. 2024; 15:1250918.

PMID: 38601463 PMC: 11004298. DOI: 10.3389/fphar.2024.1250918.

What can the common fruit fly teach us about stroke?: lessons learned from the hypoxic tolerant .

Quadros-Mennella P, Lucin K, White R Front Cell Neurosci. 2024; 18:1347980.

PMID: 38584778 PMC: 10995290. DOI: 10.3389/fncel.2024.1347980.

References

Ashabi G, Khodagholi F, Khalaj L, Goudarzvand M, Nasiri M . Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: interference of AMPK/PGC-1α pathway. Metab Brain Dis. 2014; 29(1):47-58. DOI: 10.1007/s11011-013-9475-2. View

Sato A, Sunayama J, Okada M, Watanabe E, Seino S, Shibuya K . Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK. Stem Cells Transl Med. 2012; 1(11):811-24. PMC: 3659661. DOI: 10.5966/sctm.2012-0058. View

Carreira B, Carvalho C, Araujo I . Regulation of injury-induced neurogenesis by nitric oxide. Stem Cells Int. 2012; 2012:895659. PMC: 3444935. DOI: 10.1155/2012/895659. View

Laing R, JAKUBOWSKI J, Laing R . Middle cerebral artery occlusion without craniectomy in rats. Which method works best?. Stroke. 1993; 24(2):294-7; discussion 297-8. DOI: 10.1161/01.str.24.2.294. View

Li J, Zeng Z, Viollet B, Ronnett G, McCullough L . Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke. 2007; 38(11):2992-9. PMC: 2637379. DOI: 10.1161/STROKEAHA.107.490904. View

Ergul A, Abdelsaid M, Fouda A, Fagan S . Cerebral neovascularization in diabetes: implications for stroke recovery and beyond. J Cereb Blood Flow Metab. 2014; 34(4):553-63. PMC: 3982092. DOI: 10.1038/jcbfm.2014.18. View

Ronnett G, Ramamurthy S, Kleman A, Landree L, Aja S . AMPK in the brain: its roles in energy balance and neuroprotection. J Neurochem. 2009; 109 Suppl 1:17-23. PMC: 2925428. DOI: 10.1111/j.1471-4159.2009.05916.x. View

Horn D, Barrientos A . Mitochondrial copper metabolism and delivery to cytochrome c oxidase. IUBMB Life. 2008; 60(7):421-9. PMC: 2864105. DOI: 10.1002/iub.50. View

Polonsky K . The past 200 years in diabetes. N Engl J Med. 2012; 367(14):1332-40. DOI: 10.1056/NEJMra1110560. View

10.

Foretz M, Hebrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G . Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010; 120(7):2355-69. PMC: 2898585. DOI: 10.1172/JCI40671. View

11.

Abbott N, Patabendige A, Dolman D, Yusof S, Begley D . Structure and function of the blood-brain barrier. Neurobiol Dis. 2009; 37(1):13-25. DOI: 10.1016/j.nbd.2009.07.030. View

12.

Imfeld P, Bodmer M, Jick S, Meier C . Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study. J Am Geriatr Soc. 2012; 60(5):916-21. DOI: 10.1111/j.1532-5415.2012.03916.x. View

13.

El-Mir M, Detaille D, R-Villanueva G, Delgado-Esteban M, Guigas B, Attia S . Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons. J Mol Neurosci. 2007; 34(1):77-87. DOI: 10.1007/s12031-007-9002-1. View

14.

Takahashi N, Shibata R, Ouchi N, Sugimoto M, Murohara T, Komori K . Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model. J Vasc Surg. 2014; 61(2):489-96. DOI: 10.1016/j.jvs.2013.09.061. View

15.

Takata F, Dohgu S, Matsumoto J, Machida T, Kaneshima S, Matsuo M . Metformin induces up-regulation of blood-brain barrier functions by activating AMP-activated protein kinase in rat brain microvascular endothelial cells. Biochem Biophys Res Commun. 2013; 433(4):586-90. DOI: 10.1016/j.bbrc.2013.03.036. View

16.

Moiseeva O, Deschenes-Simard X, St-Germain E, Igelmann S, Huot G, Cadar A . Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation. Aging Cell. 2013; 12(3):489-98. DOI: 10.1111/acel.12075. View

17.

Farbood Y, Sarkaki A, Khalaj L, Khodagholi F, Badavi M, Ashabi G . Targeting Adenosine Monophosphate-Activated Protein Kinase by Metformin Adjusts Post-Ischemic Hyperemia and Extracellular Neuronal Discharge in Transient Global Cerebral Ischemia. Microcirculation. 2015; 22(7):534-41. DOI: 10.1111/micc.12224. View

18.

Jung J, Lee J, Ha J, Kim S, Cho Y, Baik H . 5-Aminoimidazole-4-carboxamide-ribonucleoside enhances oxidative stress-induced apoptosis through activation of nuclear factor-kappaB in mouse Neuro 2a neuroblastoma cells. Neurosci Lett. 2004; 354(3):197-200. DOI: 10.1016/j.neulet.2003.10.012. View

19.

Ashabi G, Khalaj L, Khodagholi F, Goudarzvand M, Sarkaki A . Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia. Metab Brain Dis. 2014; 30(3):747-54. DOI: 10.1007/s11011-014-9632-2. View

20.

Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J . Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001; 108(8):1167-74. PMC: 209533. DOI: 10.1172/JCI13505. View